Literature DB >> 24675881

Role of CDK5/cyclin complexes in ischemia-induced death and survival of renal tubular cells.

Tatiana Guevara1, Mónica Sancho2, Enrique Pérez-Payá1, Mar Orzáez2.   

Abstract

Ischemia reperfusion processes induce damage in renal tubules and compromise the viability of kidney transplants. Understanding the molecular events responsible for tubule damage and recovery would help to develop new strategies for organ preservation. CDK5 has been traditionally considered a neuronal kinase with dual roles in cell death and survival. Here, we demonstrate that CDK5 and their regulators p35/p25 and cyclin I are also expressed in renal tubular cells. We show that treatment with CDK inhibitors promotes the formation of pro-survival CDK5/cyclin I complexes and enhances cell survival upon an ischemia reperfusion pro-apoptotic insult. These findings support the benefit of treating with CDK inhibitors for renal preservation, assisting renal tubule protection.

Entities:  

Keywords:  CDK5; apoptosis; ischemia reperfusion; kidney injury; renal preservation

Mesh:

Substances:

Year:  2014        PMID: 24675881      PMCID: PMC4050167          DOI: 10.4161/cc.28628

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  37 in total

1.  Delayed combinatorial treatment with flavopiridol and minocycline provides longer term protection for neuronal soma but not dendrites following global ischemia.

Authors:  Grace O Iyirhiaro; Tyson B Brust; Juliet Rashidian; Zohreh Galehdar; Aweis Osman; Maryam Phillips; Ruth S Slack; Brian A Macvicar; David S Park
Journal:  J Neurochem       Date:  2008-01-17       Impact factor: 5.372

Review 2.  Designing inhibitors of cyclin-dependent kinases.

Authors:  Ian R Hardcastle; Bernard T Golding; Roger J Griffin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

3.  Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5.

Authors:  Paola Paoletti; Ingrid Vila; Maria Rifé; José Miguel Lizcano; Jordi Alberch; Silvia Ginés
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

4.  Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma.

Authors:  Genell D Hilton; Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-09       Impact factor: 6.200

Review 5.  Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention.

Authors:  M Kosieradzki; W Rowiński
Journal:  Transplant Proc       Date:  2008-12       Impact factor: 1.066

Review 6.  Renal hypoxia and dysoxia after reperfusion of the ischemic kidney.

Authors:  Matthieu Legrand; Egbert G Mik; Tanja Johannes; Didier Payen; Can Ince
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 7.  Cerebral ischemia, cell cycle elements and Cdk5.

Authors:  Serge Timsit; Bénédicte Menn
Journal:  Biotechnol J       Date:  2007-08       Impact factor: 4.677

8.  Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability.

Authors:  Sayuko Kaminosono; Taro Saito; Fumitaka Oyama; Toshio Ohshima; Akiko Asada; Yoshitaka Nagai; Nobuyuki Nukina; Shin-Ichi Hisanaga
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

9.  The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes.

Authors:  Vasiliki Lalioti; Gemma Muruais; Ana Dinarina; Josef van Damme; Joel Vandekerckhove; Ignacio V Sandoval
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

10.  CDK5: A new lead to survival.

Authors:  John Lew
Journal:  Cell Cycle       Date:  2013-06-10       Impact factor: 4.534

View more
  5 in total

Review 1.  DNA damage response in nephrotoxic and ischemic kidney injury.

Authors:  Mingjuan Yan; Chengyuan Tang; Zhengwei Ma; Shuang Huang; Zheng Dong
Journal:  Toxicol Appl Pharmacol       Date:  2016-10-27       Impact factor: 4.219

2.  The role of PAK1 in the sensitivity of kidney epithelial cells to ischemia-like conditions.

Authors:  Evan R Zynda; Mitchell H Maloy; Eugene S Kandel
Journal:  Cell Cycle       Date:  2019-02-11       Impact factor: 4.534

3.  TFP5-Mediated CDK5 Activity Inhibition Improves Diabetic Nephropathy via NGF/Sirt1 Regulating Axis.

Authors:  Shi-Lu Cao; Hong-Yan Luo; Yong-Cai Gao; Xiao-Mei Lan; Shun-Yao Liu; Bo Li; Li Bao; Jing E; Danna Ma; Guo-Qing Zhang; Li-Rong Yang; Xi Bao; Ya-Li Zheng
Journal:  Front Cell Dev Biol       Date:  2022-07-07

4.  CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway.

Authors:  Xiaoyan Bai; Xiaoyan Hou; Jianwei Tian; Jian Geng; Xiao Li
Journal:  Oncotarget       Date:  2016-06-14

Review 5.  Cdk5 links with DNA damage response and cancer.

Authors:  Wan Liu; Jun Li; Yu-Shu Song; Yue Li; Yu-Hong Jia; Hai-Dong Zhao
Journal:  Mol Cancer       Date:  2017-03-14       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.